A CT-Based Radiomic Signature Can Be Prognostic for 10-Months Overall Survival in Metastatic Tumors Treated with Nivolumab: An Exploratory Study

Baseline clinical prognostic factors for recurrent and/or metastatic (RM) head and neck squamous cell carcinoma (HNSCC) treated with immunotherapy are lacking. CT-based radiomics may provide additional prognostic information. A total of 85 patients with RM-HNSCC were enrolled for this study. For eac...

Descripción completa

Detalles Bibliográficos
Autores principales: Corino, Valentina D. A., Bologna, Marco, Calareso, Giuseppina, Licitra, Lisa, Ghi, Mariagrazia, Rinaldi, Gaetana, Caponigro, Francesco, Morelli, Franco, Airoldi, Mario, Allegrini, Giacomo, Cassano, Alessandra, Ferrari, Daris, Mirabile, Aurora, Tosoni, Alicia, Galizia, Danilo, Merlano, Marco, Sponghini, Andrea, Moretti, Gabriella, Mainardi, Luca, Bossi, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229740/
https://www.ncbi.nlm.nih.gov/pubmed/34071518
http://dx.doi.org/10.3390/diagnostics11060979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229740/
https://www.ncbi.nlm.nih.gov/pubmed/34071518
http://dx.doi.org/10.3390/diagnostics11060979

Ejemplares similares